Cargando…
Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach
BACKGROUND: Despite a large increase in Clostridium difficile infection (CDI) severity, morbidity and mortality in the US since the early 2000s, CDI burden estimates have had limited generalizability and comparability due to widely varying clinical settings, populations, or study designs. METHODS: A...
Autores principales: | Desai, Kamal, Gupta, Swati B., Dubberke, Erik R., Prabhu, Vimalanand S., Browne, Chantelle, Mast, T. Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912810/ https://www.ncbi.nlm.nih.gov/pubmed/27316794 http://dx.doi.org/10.1186/s12879-016-1610-3 |
Ejemplares similares
-
Burden of Clostridium difficile on the Healthcare System
por: Dubberke, Erik R., et al.
Publicado: (2012) -
The Epidemiology and Economic Burden of Clostridium difficile Infection in Korea
por: Choi, Hyung-Yun, et al.
Publicado: (2015) -
Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States
por: Zhang, Dongmu, et al.
Publicado: (2018) -
The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases
por: Olsen, Margaret A., et al.
Publicado: (2016) -
Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection
por: Prabhu, Vimalanand S, et al.
Publicado: (2017)